Form D · Pharmaceuticals

Affinium Pharmaceuticals Ltd

Toronto, A6 · CIK 0001398436

Offering snapshot reported Sep 10, 2013 · SEC filing

Reported sold: $18.9M
Investors reported: 8
Minimum accepted: $0
First sale: Aug 19, 2011

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$6,999,999 → $18,900,000
Reported investors6 → 8

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Sep 10, 2013	Amendment	$18,900,000	$11,900,001vs Aug 31, 2011	8	SEC filing
Aug 31, 2011	Initial	$6,999,999	No comparison	6	SEC filing
May 21, 2010	Amendment	$18,000,000	No comparison	8	SEC filing
Apr 23, 2007	Paper	Not reported	No comparison	Not reported	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06
Duration over one year: No
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-165188

Source: Form D, filed Sep 10, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Graham Boulnois	Director
Hamish Cameron	Director
Stuart J.M. Collinson	Director
Damian Lamb	Director
Edward Mascioli	Director, Executive
Robert Radie	Director
Owen G. Roberts	Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

200 Front Street West Suite 3004
Toronto, A6, M5V 3K2